• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY CMW - 9610921 DEPUY/CMW 2G; BONE CEMENT : BONE CEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY CMW - 9610921 DEPUY/CMW 2G; BONE CEMENT : BONE CEMENT Back to Search Results
Model Number 5450-32-500
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Nerve Damage (1979); Pain (1994); Loss of Range of Motion (2032); Numbness (2415); Paresthesia (4421)
Event Date 09/03/2020
Event Type  Injury  
Manufacturer Narrative
Product complaint # (b)(4).Dmf# - (b)(4).Trade name gentamicin sulphate.Active ingredient(s) gentamicin sulphate.Dosage form - powder.Strength 1.0g active in our cements.Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.Corrected report source.
 
Event Description
Clinical adverse event received for pain in shoulder region after shoulder replacement; chronic pain event is not serious and is considered mild.Event is possibly related to procedure.Event is not related to device.Date of implant: (b)(6) 2020.Date of event: (b)(6) 2020.(right shoulder).Treatment: initial work up for infection with blood work.
 
Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.H10 additional narrative:  if information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event Description
Patient underwent a successful anatomic shoulder arthroplasty on (b)(6) 2020.Post-operative clinic visit on (b)(6) 2020 states she is having brachial plexopathy symptoms along the c6 dermatome (pain and decreased sensation to be captured as nerve injury).On (b)(6) 2021, the patient continues to have strength and range of motion limitations requiring more physical therapy.She has lateral shoulder pain over the lateral acromion/subacromial space.Xray review shows some ¿minor stress shield related resorption of medial humeral calcar when compared to previous xrays¿.Clinic visit on (b)(6) 2022 states she has ongoing pain and in 4 weeks will have blood drawn to check crp, esr and wbc for potential infection as the source of her pain.The numbness and tingling on the radial aspect of the right forearm and tip of the thumb is still present and likely to not improve.
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary : the device associated with this report was not returned to depuy synthes for evaluation.All available x-rays were reviewed, and no evidence of implant fracture, disassociation, or anything indicative of a device nonconformance was found.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post-market safety surveillance activities.Device history lot : a search of the depuy nonconformance (nc) quality system found no nc¿s associated with this product/lot combination.Based on the inability to find any nc¿s against the provided product code/lot code combination, it is reasonable to conclude that there are no anomalies with regard to manufacturing or inspection contained in the device history records that would contribute to the reported event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DEPUY/CMW 2G
Type of Device
BONE CEMENT : BONE CEMENT
Manufacturer (Section D)
DEPUY CMW - 9610921
cornford rd.
blackpool IN FY4 4 QQ
UK  FY4 4QQ
Manufacturer (Section G)
DEPUY CMW - 9610921
cornford rd
blackpool FY4 4 QQ
UK   FY4 4QQ
Manufacturer Contact
kate karberg
700 orthopaedic dr.
warsaw, IN 46581-0988
3035526892
MDR Report Key15952031
MDR Text Key305188966
Report Number1818910-2022-24949
Device Sequence Number1
Product Code MBB
UDI-Device Identifier20603295174278
UDI-Public10603295174271
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K081163
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 12/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/09/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number5450-32-500
Device Catalogue Number545032500
Device Lot Number9309955
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/13/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CROSSLINK ANCHOR PG GLENOID 48; DEPUY/CMW 2G; GLBL UNITE ANT BODY 135 SZ 12; GLOBAL UNITE HEAD 48X18 ECC; GLOBAL UNITE STD STEM SZ 12
Patient Outcome(s) Required Intervention;
Patient Age73 YR
Patient SexFemale
Patient Weight95 KG
-
-